TWC
NBIX icon

TD Waterhouse Canada’s Neurocrine Biosciences NBIX Stock Holding History

TD Waterhouse Canada’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.38K Buy
+50
New +$7.42K ﹤0.01% 1871
2024
Q2 		– Sell
-41
Closed -$5.64K – 1963
2024
Q1 		$5.64K Buy
+41
New +$5.6K ﹤0.01% 1510
2023
Q4 		– Sell
-19
Closed -$2.12K – 1771
2023
Q3 		$2.12K Hold
19
– – ﹤0.01% 1492
2023
Q2 		$1.79K Hold
19
– – ﹤0.01% 1549
2023
Q1 		$1.92K Hold
19
– – ﹤0.01% 1522
2022
Q4 		$2.28K Buy
+19
New +$2.23K ﹤0.01% 1470

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

TD Waterhouse Canada's NBIX Position: Q2 2026 in Review

TD Waterhouse Canada opened a new position in Neurocrine Biosciences (NBIX) in Q2 2026: 50 shares worth $8.38K. The stake represents ﹤0.01% of the portfolio and ranks #1871 among its holdings. This is a return to the name: TD Waterhouse Canada previously reported a position in NBIX as recently as Q1 2024.

TD Waterhouse Canada first reported a position in NBIX in Q4 2022 and has held it in 6 quarters since. 781 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • TD Waterhouse Canada held 50 shares of Neurocrine Biosciences worth $8.38K as of Q2 2026.
  • Neurocrine Biosciences was a new TD Waterhouse Canada position in Q2 2026.
  • Neurocrine Biosciences made up ﹤0.01% of TD Waterhouse Canada's portfolio in Q2 2026, its #1871 holding.
  • TD Waterhouse Canada first reported a position in Neurocrine Biosciences in Q4 2022 and has held it in 6 quarters since.
  • 781 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on TD Waterhouse Canada's 13F filing for Q2 2026, filed 27 Jul 2026.